|
AMXT 1501 Dicaprate Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: AMXT 1501
Little Rock, Arkansas1 trial
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Arkansas Children's Hospital
Phase 1/2
Lake Success, New York1 trial
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
START Cancer Research New York-Long Island
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.